Formulary
Bevacizumab [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Bevacizumab [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Bevacizumab [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Bevacizumab [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Colorectal cancer,Breast cancer,Renal cell carcinoma,Non-small cell lung cancer,Epithelial ovarian cancer,Fallopian tube cancer,Peritoneal cancer,Cervical carcinoma**
- **Adult** (By Intravenous Infusion): Specialist drug - access specialist resources for dosing information.
Contraindications
For bevacizumab [Specialist drug] With intravitreal use Intra-ocular inflammation (active); ocular or peri-ocular infection
Side effects
For bevacizumab [Specialist drug] General side-effects: Common or very common Eye disorders; haemorrhage Specific side-effects: Common or very common With intravenous use Abscess; anaemia; appetite decreased; arthralgia; asthenia; congestive heart failure; constipation; cough; decreased leucocytes; dehydration; diarrhoea; drowsiness; dysarthria; dysphonia; dyspnoea; electrolyte imbalance; embolism and thrombosis; fever; fistula; gastrointestinal discomfort; gastrointestinal disorders; headache; healing impaired; hypersensitivity; hypertension; hypoxia; increased risk of infection; infusion related reaction; mucositis; muscle weakness; myalgia; nausea; neutropenia; ovarian failure; pain; pelvic pain; peripheral neuropathy; proteinuria; rectovaginal fistula; sepsis; skin reactions; stomatitis; stroke; supraventricular tachycardia; syncope; taste altered; thrombocytopenia; vomiting; weight decreased With intravitreal use Eye discomfort Uncommon With intravitreal use Dry eye; eye inflammation; retinal pigment epithelial tear; vision disorders Rare or very rare With intravenous use Encephalopathy; necrotising fasciitis (discontinue and initiate treatment promptly) Frequency not known With intravenous use Aneurysm; artery dissection; chest pain; chills; flushing; gallbladder perforation; hyperglycaemia; hypotension; nasal septum perforation; osteonecrosis of jaw; pulmonary hypertension; renal thrombotic microangiopathy With intravitreal use Arterial thromboembolism Side-effects, further information Intravitreal use Discontinue treatment in the event of rhegmatogenous retinal detachment, or if stage 3 or 4 macular holes develop.
Medicinal forms
Solution,Solution,Solution
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Bevacizumab [Specialist drug] in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

